Geneos Wealth Management’s Credo Technology Group CRDO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$859K Sell
9,147
-3,753
-29% -$457K 0.02% 547
2025
Q4
$1.86M Sell
12,900
-8,513
-40% -$1.31M 0.05% 366
2025
Q3
$3.12M Buy
21,413
+13
+0.1% +$1.59K 0.08% 277
2025
Q2
$1.98M Sell
21,400
-30,588
-59% -$1.78M 0.05% 374
2025
Q1
$2.09M Buy
51,988
+51,921
+77,494% +$3.23M 0.03% 479
2024
Q4
$4.5K Buy
+67
New +$3.33K ﹤0.01% 2376

Other funds holding CRDO

Geneos Wealth Management's CRDO Position: Q1 2026 in Review

Geneos Wealth Management reduced its Credo Technology Group (CRDO) stake by 29% in Q1 2026, selling an estimated $457K and leaving 9,147 shares worth $859K. The position accounts for 0.02% of the portfolio, ranked #547.

Geneos Wealth Management first reported a position in CRDO in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.12M in Q3 2025. 709 funds tracked by Wall St. Rank hold CRDO as of Q1 2026.

  • Geneos Wealth Management held 9,147 shares of Credo Technology Group worth $859K as of Q1 2026.
  • Geneos Wealth Management sold 3,753 Credo Technology Group shares in Q1 2026, an estimated $457K.
  • Credo Technology Group made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #547 holding.
  • Geneos Wealth Management first reported a position in Credo Technology Group in Q4 2024 and has held it in 6 quarters since.
  • Geneos Wealth Management's Credo Technology Group position peaked at $3.12M in Q3 2025.
  • 709 funds tracked by Wall St. Rank held Credo Technology Group as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.